Evidence map›Paper›PMID 36974106›Full record

ArticleJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2023

Cardioembolic stroke, the most common subtype of stroke in COVID 19: A single center experience from Isfahan, Iran.

Marzieh Tajmirriahi, Maryam Masjedi Esfahani, Zahra Amouaghaei, Nahid Mansori, Pantea Miralaei, Sahar Sadat Lalehzar, Peiman Shirani, Mohammad Saadatnia

Open access · goldAbstract read
In one paragraph

Article in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Marzieh TajmirriahiIsfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Maryam Masjedi EsfahaniIsfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Zahra AmouaghaeiIsfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Nahid MansoriIsfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Pantea MiralaeiIsfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Sahar Sadat LalehzarIsfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Peiman ShiraniIsfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad SaadatniaIsfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Isfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Some studies showed the cerebrovascular manifestation in patients with recently pandemic coronavirus 2 named the coronavirus disease 2019 (COVID-19). However, there are rare reports about stroke subtypes in these patients. Here, we reported the stroke subtype in patients with laboratory-confirmed diagnosis of COVID-19 and treated at our hospitals, which are located in Isfahan, Iran. Materials and Methods: This is a retrospective, observational case series. Data were collected from March 01, 2020, to May 20, 2020, at three designated special care centers for COVID-19 of Isfahan University of Medical Sciences. The study included 1188 consecutive hospitalized patients with laboratory-confirmed diagnosis of COVID-19. Results: Of 1188 COVID-19 patients, 7 (0.5%) patients developed stroke. Five (0.4%) had ischemic arterial stroke, 1 (0.08%) hemorrhagic stroke and 1(0.08 %) cerebral venous and sinus thrombosis. Sixty percent of ischemic stroke were cardioembolic stroke (CE) and the rest 2 (40%) were embolic stroke of undetermined source. Three male patients (40%) had stroke as a presenting and admitted symptom of COVID-19. Four patients (57%) had severe COVID-19. Conclusion: Stroke was an uncommon manifestation in COVID-19 patients. CE was a common subtype of stroke in COVID-19 patients in our centers.

Indexed as

COVID-19embolic strokeinfectionstroke

Identifiers

PMID36974106
PMCPMC10039102
OpenAlexW4321461749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.